V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160016429 | 160020458 | 1.74 | 88.1 | Curative (C) | 2017-10-02 | 2017-10-14 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 100736808 |
| 160016440 | 160020459 | 1.52 | 74 | Palliative (P) | 2019-01-15 | 2019-08-26 | Bevacizumab 15mg/kg | 02 | N | DOCETAXEL + GEMCITABINE | 100907107 |
| 160016447 | 160020460 | 1.75 | 72.5 | Palliative (P) | 2021-04-09 | 2021-04-17 | Bevacizumab 15mg/kg | 2 | null | LIPOSOMAL DOXORUBICIN | 101003237 |
| 160016540 | 160020461 | 1.64 | 69.6 | Neo-adjuvant (N) | 2021-10-14 | 2022-03-30 | Bevacizumab | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101003034 |
| 160016547 | 160020462 | 1.59 | 77 | Palliative (P) | 2019-11-01 | 2020-05-15 | Bevacizumab 7.5mg/kg | 02 | N | PACLITAXEL | 100387025 |
| 160016636 | 160020463 | 1.74 | 107.6 | Palliative (P) | 2021-08-01 | 2021-08-12 | DOCETAXEL + GEMCITABINE | N | N | DOCETAXEL + GEMCITABINE | 100921383 |
| 160016640 | 160020464 | 1.6 | 41 | null | 2020-06-23 | 2020-09-05 | Niraparib | 02 | null | NIRAPARIB | 100225927 |
| 160016710 | 160020465 | 0 | 105.8 | Adjuvant (A) | 2017-03-28 | 2017-04-07 | BRIGATINIB | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100954690 |
| 160016749 | 160020466 | 0 | 8.5 | null | 2019-06-03 | 2019-10-16 | STS Rhabdomyosarcoma RMS 2005 VA | 02 | null | TRIAL | 100080250 |
| 160016779 | 160020467 | 1.77 | 93.9 | Palliative (P) | 2021-11-04 | 2021-11-21 | Carboplatin + Liposomal Doxorubicin | 02 | N | ETOPOSIDE | 100909788 |
| 160016811 | 160020468 | 0 | 73.5 | null | null | null | CYCLO + DOXORUBICIN + VINCRISTINE | 02 | null | NB HRNBL-1 ISOTRETINOIN | 100428216 |
| 160016868 | 160020469 | 0 | 90 | null | 2021-01-27 | 2021-01-30 | Cyclophosphamide + Vincristine | 02 | null | TEMOZOLOMIDE | 101197738 |
| 160016921 | 160020470 | 1.63 | 40.9 | Curative (C) | 2022-04-16 | 2022-05-14 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | ETOP 13-18 BEAT-MESO TRIAL | 100601969 |
| 160016955 | 160020471 | 0 | 73 | null | 2019-08-07 | 2019-08-07 | GEMCITABINE | 02 | null | NOT MATCHED | 101863220 |
| 160016959 | 160020472 | 0 | 46.1 | null | 2022-01-05 | 2022-05-07 | VAI (Ifos 3g/m2) | 02 | null | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 100659204 |
| 160016975 | 160020473 | 1.79 | 34.4 | Curative (C) | 2020-06-13 | 2021-01-16 | NB HRNBL-1 COJEC Ind COURSE C | 02 | N | EW EUROEWING 2012 ARM A/B ZOL ACID | 100761456 |
| 160016986 | 160020474 | 1.86 | 63.5 | null | 2018-11-24 | 2019-05-02 | Doxorubicin + Ifosfamide | 02 | null | CYCLOPHOSPHAMIDE + VINCRISTINE | 100200365 |
| 160016993 | 160020475 | 1.7 | 18.5 | Palliative (P) | 2021-01-27 | 2021-02-11 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | STS RHABDOMYOSARCOMA RMS 2005 IVA | 100212183 |
| 160017030 | 160020476 | 1.6 | 73.02 | Curative (C) | 2017-11-30 | 2018-01-25 | STS Non-Rhabdo EpSSG 2005 Ifos | 02 | null | NAB-PACLITAXEL | 101823003 |
| 160017140 | 160020477 | 1.57 | 19.2 | Neo-adjuvant (N) | 2021-07-11 | 2021-07-13 | TIP | Y | N | STS RHABDOMYOSARCO RMS 2005 IVADOVV | 100022048 |
| 160017143 | 160020478 | 1.36 | 85.2 | Adjuvant (A) | 2022-03-21 | 2022-04-18 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | EW EUROEWING 2012 ARM B VC | 101237274 |
| 160017159 | 160020479 | 1.59 | 28.3 | Palliative (P) | 2021-08-07 | 2021-08-11 | null | 02 | null | CYCLOPHOSPHAMIDE + VINORELBINE | 101794810 |
| 160017164 | 160020480 | 1.62 | 71.5 | Curative (C) | 2020-11-23 | 2020-11-25 | Doxorubicin + Ifosfamide | 02 | N | OLAPARIB | 100139910 |
| 160017216 | 160020481 | 1.56 | 15.3 | null | 2019-01-30 | 2019-11-09 | VINCRISTINE | 02 | null | GEMCITABINE | 101196585 |
| 160017388 | 160020482 | 0 | 59.6 | null | 2022-03-04 | 2022-03-11 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | null | DOXORUBICIN + IFOSFAMIDE | 101109548 |
| 160017396 | 160020483 | 1.14 | 112.45 | Palliative (P) | 2021-03-24 | 2021-04-18 | VAC | 02 | N | EW EUROEWING 2012 ARM B IE | 101280426 |
| 160017419 | 160020484 | 1.77 | 68 | Palliative (P) | 2016-09-27 | 2016-10-01 | Ipilimumab | 01 | N | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 100343892 |
| 160002009 | 160020486 | 1.79 | 71.5 | null | 2020-08-10 | 2020-08-17 | EW EuroEwing 2012 Arm B IE | 02 | null | DOXORUBICIN + IFOSFAMIDE | 100169851 |
| 160005199 | 160020487 | null | 60.8 | Palliative (P) | 2020-01-08 | 2020-01-08 | null | N | N | CONFIRM TRIAL | 100797738 |
| 160010801 | 160020489 | 1.62 | 17.4 | Palliative (P) | 2017-10-25 | 2017-10-26 | PROMISE-MESO TRIAL | 02 | N | STS RHABDOMYOSARCOMA RMS 2005 IVA | 100508709 |
| 160011377 | 160020490 | null | 70.1 | Palliative (P) | 2021-09-12 | 2021-09-14 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | N | TRIAL | 100726833 |
| 160016734 | 160020491 | 1.7 | 61.5 | null | 2019-02-19 | 2019-02-20 | Olaparib | 02 | null | CISPLATIN + GEMCITABINE | 100068510 |
| 160014994 | 160020511 | 1.6 | 73.7 | Palliative (P) | 2017-10-12 | 2017-10-26 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100444770 |
| 160015074 | 160020512 | 1.54 | 75.6 | Palliative (P) | 2019-08-18 | 2020-01-16 | Doxorubicin 75mg/m2 | N | N | TRIAL UNSPECIFIED | 100160974 |
| 160015290 | 160020513 | 1.82 | 63.8 | Palliative (P) | 2017-09-01 | 2017-09-15 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101658935 |
| 160015343 | 160020514 | 1.79 | 84 | null | 2022-02-18 | 2022-02-18 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100568238 |
| 160015442 | 160020515 | 1.57 | 84.6 | null | 2020-11-29 | 2020-11-29 | Trabectedin | 02 | null | TRABECTEDIN | 100059880 |
| 160015449 | 160020516 | 1.74 | 72 | null | null | null | Vinorelbine (weekly iv) | 02 | null | VINORELBINE | 101614057 |
| 160015528 | 160020517 | 1.72 | 81.8 | Palliative (P) | 2017-04-18 | 2017-04-30 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101653921 |
| 160015535 | 160020518 | 1.62 | 79.5 | Palliative (P) | 2020-06-20 | 2020-06-21 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN + PACLITAXEL | 101424685 |
| 160015679 | 160020519 | 1.6 | 82.15 | Palliative (P) | 2021-05-09 | 2021-05-15 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 100494943 |
| 160015916 | 160020520 | 1.69 | 49.8 | Palliative (P) | 2017-10-21 | 2017-11-07 | DOCETAXEL + GEMCITABINE | 02 | N | DOCETAXEL + GEMCITABINE | 101853045 |
| 160015969 | 160020521 | 1.86 | 57.6 | Palliative (P) | 2018-05-22 | 2018-12-29 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN | 101127652 |
| 160016071 | 160020522 | 1.52 | 89 | null | 2020-01-28 | 2020-01-28 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101610285 |
| 160016215 | 160020523 | 1.73 | 110.4 | Palliative (P) | 2018-10-05 | 2018-10-12 | CARBOPLATIN + PACLITAXEL | 02 | null | CARBOPLATIN + PACLITAXEL | 101711099 |
| 160016304 | 160020524 | 1.87 | 69 | Palliative (P) | 2019-12-13 | 2020-01-02 | Bevacizumab | 02 | N | CARBOPLATIN + PACLITAXEL | 100017071 |
| 160016323 | 160020525 | 1.68 | 95.9 | null | 2022-01-29 | 2022-02-12 | Bevacizumab | 02 | null | CARBOPLATIN + PACLITAXEL | 101402071 |
| 160016440 | 160020526 | 1.67 | 57.3 | Palliative (P) | 2019-05-25 | 2019-11-12 | Bevacizumab | 02 | null | BEVACIZUMAB | 100907107 |
| 160016447 | 160020527 | 1.83 | 68.5 | Palliative (P) | 2021-05-27 | 2021-05-28 | Bevacizumab | 02 | N | CARBOPLATIN + PACLITAXEL | 101003237 |
| 160016540 | 160020528 | 1.71 | 87 | Palliative (P) | 2022-04-12 | 2022-05-07 | Bevacizumab 7.5mg/kg | 02 | N | CISPLATIN + PEMETREXED | 101003034 |